chenodeoxycholic acid has been researched along with Chronic Hepatitis C in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rockey, DC | 1 |
| Brites, D; Costa, A; De Moura, MC; Ramalho, F; Rodrigues, CM; Serejo, F | 1 |
2 other study(ies) available for chenodeoxycholic acid and Chronic Hepatitis C
| Article | Year |
|---|---|
Editorial: Advances in Hepatology: 2019.
Topics: Antiviral Agents; Blood Coagulation Disorders; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; End Stage Liver Disease; Gastroenterology; Hepatic Encephalopathy; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Non-alcoholic Fatty Liver Disease; Palliative Care | 2019 |
Apoptotic cell death does not parallel other indicators of liver damage in chronic hepatitis C patients.
Topics: Adult; Aged; Apoptosis; Bile Acids and Salts; Biomarkers; Biopsy; Chenodeoxycholic Acid; Chromatography, Gas; DNA Fragmentation; Female; Hepatitis C, Chronic; Histological Techniques; Humans; Liver; Male; Middle Aged | 2000 |